Peng Li
Yangtze River Pharmaceutical Group (China)
ORCID: 0000-0002-3362-0543Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 8 papers. Top paper: “CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia”.
Di Wu, Shouheng Lin, Peng Li, Zhiwu Jiang
Liang Ma, John P. Dekker, Pavel P. Khil, Jung-Ho Youn, Jason M. Brenchley +20 more
Ke Hu, Lingzhong Fan, Hao Yan, Peng Li, Tianzi Jiang +2 more
Zehua Chen, Da Wei Huang, Ousmane H. Cissé, Jamie L. Rothenburger, Alice Latinne +28 more
Peng Li, Claire M. Jardine, Jamie L. Rothenburger, Mark T. Swanson, Joseph A. Kovacs +4 more
Ming Hao, Weizhong Chang, Xilong Deng, J. F. Sun, Marwan M. Azar +24 more
Maozi Hu, Xiaolu Peng, Yuan Gong, Keli Qian, Junnan Li +9 more
Ting He, Xiujun Li, Xue Wang, Peng Li, Liang Ma +1 more